Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Amino-Terminus-Modified Eosinophil-Derived Neurotoxin and its Selective Toxicity to Kaposi's Sarcoma Cell Line KS-Y-1

  • Read more about Amino-Terminus-Modified Eosinophil-Derived Neurotoxin and its Selective Toxicity to Kaposi's Sarcoma Cell Line KS-Y-1
US Application 60/106,732
Filed on 1998-11-02

P53 and VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells

  • Read more about P53 and VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells
US Application 60/109,563
Filed on 1998-11-23

Virus-Like Particles for the Induction of Autoantibodies

  • Read more about Virus-Like Particles for the Induction of Autoantibodies
US Application 60/105,132
Filed on 1998-10-21

Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods--

  • Read more about Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods--
US Application 60/114,868
Filed on 1999-01-06

SPECIFIC KILLING OF HIV-INFECTED LYMPHOCYTES BY A RECOMBINANT IMMUNOTOXIN DIRECTED AGAINST THE HIV-1 GP 120 ENVELOPE GLYCOPROTEIN

  • Read more about SPECIFIC KILLING OF HIV-INFECTED LYMPHOCYTES BY A RECOMBINANT IMMUNOTOXIN DIRECTED AGAINST THE HIV-1 GP 120 ENVELOPE GLYCOPROTEIN
US Application 60/088,860
Filed on 1998-06-11

Multidrug-Resistant Retroviral Protease Inhibitors, Compostions and Uses Thereof, Bioassay Methods, and Synthesis Methods

  • Read more about Multidrug-Resistant Retroviral Protease Inhibitors, Compostions and Uses Thereof, Bioassay Methods, and Synthesis Methods
US Application 60/090,393
Filed on 1998-06-23

Calcium Channel Compositions and Methods of Use Thereof

  • Read more about Calcium Channel Compositions and Methods of Use Thereof
US Application 60/114,359
Filed on 1998-12-30

Modified HCV Peptide Vaccine

  • Read more about Modified HCV Peptide Vaccine
US Application 60/097,446
Filed on 1998-08-21

Water-Soluble Drugs and Method of Preparing Same

  • Read more about Water-Soluble Drugs and Method of Preparing Same
US Application 60/093,284
Filed on 1998-07-17

Novel 2-Alkoxy Estradiols and Derivatives Thereof

  • Read more about Novel 2-Alkoxy Estradiols and Derivatives Thereof
US Application 60/040,540
Filed on 1997-03-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health